Montvale Technologies Inc
OTC:IVVI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Montvale Technologies Inc
OTC:IVVI
|
US |
|
transcosmos Inc
TSE:9715
|
JP |
|
ISC Business Technology AG
F:I5Q1
|
CH |
|
N
|
Noble Metal Group Inc
OTC:NBMLF
|
CA |
|
Huicheng International Holdings Ltd
OTC:COUTF
|
CN |
|
Kavango Resources PLC
LSE:KAV
|
UK |
|
L
|
Lavras Gold Corp
XTSX:LGC
|
CA |
|
R
|
Rambus Inc
DUS:RMB
|
US |
|
ATAC Resources Ltd
XTSX:ATC
|
CA |
|
G
|
Glory Sun Land Group Ltd
HKEX:299
|
HK |
Montvale Technologies Inc
Ivivi Technologies, Inc. engages in the design, development, and commercialize of proprietary electrotherapeutic technologies for the non-invasive treatment of acute and chronic disorders of soft tissue. The company is headquartered in Northvale, New Jersey and currently employs 15 full-time employees. The company went IPO on 2006-10-19. The firm has focused its research and development activities on targeted pulsed electromagnetic field (tPEMF) technology. The firm is marketing products utilizing its tPEMF technology to various surgery markets for adjunctive use in the treatment of post operative pain and edema in superficial soft tissue. The firm is developing technology for other therapeutic medical markets.
Ivivi Technologies, Inc. engages in the design, development, and commercialize of proprietary electrotherapeutic technologies for the non-invasive treatment of acute and chronic disorders of soft tissue. The company is headquartered in Northvale, New Jersey and currently employs 15 full-time employees. The company went IPO on 2006-10-19. The firm has focused its research and development activities on targeted pulsed electromagnetic field (tPEMF) technology. The firm is marketing products utilizing its tPEMF technology to various surgery markets for adjunctive use in the treatment of post operative pain and edema in superficial soft tissue. The firm is developing technology for other therapeutic medical markets.
